Interaction of a non-peptide agonist with angiotensin II AT(1) receptor mutants

Detalhes bibliográficos
Autor(a) principal: Costa-Neto, Claudio Miguel
Data de Publicação: 2002
Outros Autores: Miyakawa, Ayumi A., Pesquero, João Bosco [UNIFESP], Oliveira, Laerte, Hjorth, Siv A., Schwartz, Thue W., Paiva, Antonio Cechelli de Mattos [UNIFESP]
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da UNIFESP
Texto Completo: http://dx.doi.org/10.1139/Y02-058
http://repositorio.unifesp.br/handle/11600/26837
Resumo: To identify residues of the rat AT(1A) angiotensin II receptor involved with signal transduction and binding of the non-peptide agonist L-162,313 (5,7-dimethyl-2-ethyl-3-[[4-[2(n-butyloxycarbonylsulfonamido)-5-isobutyl-3-thienyl]phenyl]methyl]imidazol[4,5,6]-pyridine) we have performed ligand binding and inositol phosphate turnover assays in COS-7 cells transiently transfected with the wild-type and mutant forms of the receptor. Mutant receptors bore modifications in the extracellular region: T88H, Y92H, G196I, G196W, and D278E. Compound L-162,313 displaced [I-125]-Sar(1),Leu(8)-AngII from the mutants G196I and G196W with IC50 values similar to that of the wild-type. the affinity was, however, slightly affected by the D278E mutation and more significantly by the T88H and Y92H mutations. in inositol phosphate turnover assays, the ability of L-162,313 to trigger the activation cascade was compared with that of angiotensin II. These assays showed that the G196W mutant reached a relative maximum activation exceeding that of the wild-type receptor; the efficacy was slightly reduced in the G196I mutant and further reduced in the T88H, Y92H, and D278E mutants. Our data suggest that residues of the extracellular domain of the AT(1) receptor are involved in the binding of the non-peptide ligand, or in a general receptor activation phenomenon that involves conformational modifications for a preferential binding of agonists or antagonists.
id UFSP_8ac1b179600d2b014e53a87dcdc292f7
oai_identifier_str oai:repositorio.unifesp.br/:11600/26837
network_acronym_str UFSP
network_name_str Repositório Institucional da UNIFESP
repository_id_str 3465
spelling Interaction of a non-peptide agonist with angiotensin II AT(1) receptor mutantsangiotensinreceptorGPCRnon-peptide agonisttransductionTo identify residues of the rat AT(1A) angiotensin II receptor involved with signal transduction and binding of the non-peptide agonist L-162,313 (5,7-dimethyl-2-ethyl-3-[[4-[2(n-butyloxycarbonylsulfonamido)-5-isobutyl-3-thienyl]phenyl]methyl]imidazol[4,5,6]-pyridine) we have performed ligand binding and inositol phosphate turnover assays in COS-7 cells transiently transfected with the wild-type and mutant forms of the receptor. Mutant receptors bore modifications in the extracellular region: T88H, Y92H, G196I, G196W, and D278E. Compound L-162,313 displaced [I-125]-Sar(1),Leu(8)-AngII from the mutants G196I and G196W with IC50 values similar to that of the wild-type. the affinity was, however, slightly affected by the D278E mutation and more significantly by the T88H and Y92H mutations. in inositol phosphate turnover assays, the ability of L-162,313 to trigger the activation cascade was compared with that of angiotensin II. These assays showed that the G196W mutant reached a relative maximum activation exceeding that of the wild-type receptor; the efficacy was slightly reduced in the G196I mutant and further reduced in the T88H, Y92H, and D278E mutants. Our data suggest that residues of the extracellular domain of the AT(1) receptor are involved in the binding of the non-peptide ligand, or in a general receptor activation phenomenon that involves conformational modifications for a preferential binding of agonists or antagonists.Universidade Federal de São Paulo, Escola Paulista Med, Dept Biophys, BR-04023062 São Paulo, BrazilUniv Copenhagen, Panum Inst, Mol Pharmacol Lab, DK-2200 Copenhagen, DenmarkUniversidade Federal de São Paulo, Escola Paulista Med, Dept Biophys, BR-04023062 São Paulo, BrazilWeb of ScienceNatl Research Council CanadaUniversidade Federal de São Paulo (UNIFESP)Univ CopenhagenCosta-Neto, Claudio MiguelMiyakawa, Ayumi A.Pesquero, João Bosco [UNIFESP]Oliveira, LaerteHjorth, Siv A.Schwartz, Thue W.Paiva, Antonio Cechelli de Mattos [UNIFESP]2016-01-24T12:33:21Z2016-01-24T12:33:21Z2002-05-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersion413-417http://dx.doi.org/10.1139/Y02-058Canadian Journal of Physiology and Pharmacology. Ottawa: Natl Research Council Canada, v. 80, n. 5, p. 413-417, 2002.10.1139/Y02-0580008-4212http://repositorio.unifesp.br/handle/11600/26837WOS:000175428800008engCanadian Journal of Physiology and Pharmacologyinfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da UNIFESPinstname:Universidade Federal de São Paulo (UNIFESP)instacron:UNIFESP2016-01-24T10:33:21Zoai:repositorio.unifesp.br/:11600/26837Repositório InstitucionalPUBhttp://www.repositorio.unifesp.br/oai/requestbiblioteca.csp@unifesp.bropendoar:34652016-01-24T10:33:21Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)false
dc.title.none.fl_str_mv Interaction of a non-peptide agonist with angiotensin II AT(1) receptor mutants
title Interaction of a non-peptide agonist with angiotensin II AT(1) receptor mutants
spellingShingle Interaction of a non-peptide agonist with angiotensin II AT(1) receptor mutants
Costa-Neto, Claudio Miguel
angiotensin
receptor
GPCR
non-peptide agonist
transduction
title_short Interaction of a non-peptide agonist with angiotensin II AT(1) receptor mutants
title_full Interaction of a non-peptide agonist with angiotensin II AT(1) receptor mutants
title_fullStr Interaction of a non-peptide agonist with angiotensin II AT(1) receptor mutants
title_full_unstemmed Interaction of a non-peptide agonist with angiotensin II AT(1) receptor mutants
title_sort Interaction of a non-peptide agonist with angiotensin II AT(1) receptor mutants
author Costa-Neto, Claudio Miguel
author_facet Costa-Neto, Claudio Miguel
Miyakawa, Ayumi A.
Pesquero, João Bosco [UNIFESP]
Oliveira, Laerte
Hjorth, Siv A.
Schwartz, Thue W.
Paiva, Antonio Cechelli de Mattos [UNIFESP]
author_role author
author2 Miyakawa, Ayumi A.
Pesquero, João Bosco [UNIFESP]
Oliveira, Laerte
Hjorth, Siv A.
Schwartz, Thue W.
Paiva, Antonio Cechelli de Mattos [UNIFESP]
author2_role author
author
author
author
author
author
dc.contributor.none.fl_str_mv Universidade Federal de São Paulo (UNIFESP)
Univ Copenhagen
dc.contributor.author.fl_str_mv Costa-Neto, Claudio Miguel
Miyakawa, Ayumi A.
Pesquero, João Bosco [UNIFESP]
Oliveira, Laerte
Hjorth, Siv A.
Schwartz, Thue W.
Paiva, Antonio Cechelli de Mattos [UNIFESP]
dc.subject.por.fl_str_mv angiotensin
receptor
GPCR
non-peptide agonist
transduction
topic angiotensin
receptor
GPCR
non-peptide agonist
transduction
description To identify residues of the rat AT(1A) angiotensin II receptor involved with signal transduction and binding of the non-peptide agonist L-162,313 (5,7-dimethyl-2-ethyl-3-[[4-[2(n-butyloxycarbonylsulfonamido)-5-isobutyl-3-thienyl]phenyl]methyl]imidazol[4,5,6]-pyridine) we have performed ligand binding and inositol phosphate turnover assays in COS-7 cells transiently transfected with the wild-type and mutant forms of the receptor. Mutant receptors bore modifications in the extracellular region: T88H, Y92H, G196I, G196W, and D278E. Compound L-162,313 displaced [I-125]-Sar(1),Leu(8)-AngII from the mutants G196I and G196W with IC50 values similar to that of the wild-type. the affinity was, however, slightly affected by the D278E mutation and more significantly by the T88H and Y92H mutations. in inositol phosphate turnover assays, the ability of L-162,313 to trigger the activation cascade was compared with that of angiotensin II. These assays showed that the G196W mutant reached a relative maximum activation exceeding that of the wild-type receptor; the efficacy was slightly reduced in the G196I mutant and further reduced in the T88H, Y92H, and D278E mutants. Our data suggest that residues of the extracellular domain of the AT(1) receptor are involved in the binding of the non-peptide ligand, or in a general receptor activation phenomenon that involves conformational modifications for a preferential binding of agonists or antagonists.
publishDate 2002
dc.date.none.fl_str_mv 2002-05-01
2016-01-24T12:33:21Z
2016-01-24T12:33:21Z
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://dx.doi.org/10.1139/Y02-058
Canadian Journal of Physiology and Pharmacology. Ottawa: Natl Research Council Canada, v. 80, n. 5, p. 413-417, 2002.
10.1139/Y02-058
0008-4212
http://repositorio.unifesp.br/handle/11600/26837
WOS:000175428800008
url http://dx.doi.org/10.1139/Y02-058
http://repositorio.unifesp.br/handle/11600/26837
identifier_str_mv Canadian Journal of Physiology and Pharmacology. Ottawa: Natl Research Council Canada, v. 80, n. 5, p. 413-417, 2002.
10.1139/Y02-058
0008-4212
WOS:000175428800008
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv Canadian Journal of Physiology and Pharmacology
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv 413-417
dc.publisher.none.fl_str_mv Natl Research Council Canada
publisher.none.fl_str_mv Natl Research Council Canada
dc.source.none.fl_str_mv reponame:Repositório Institucional da UNIFESP
instname:Universidade Federal de São Paulo (UNIFESP)
instacron:UNIFESP
instname_str Universidade Federal de São Paulo (UNIFESP)
instacron_str UNIFESP
institution UNIFESP
reponame_str Repositório Institucional da UNIFESP
collection Repositório Institucional da UNIFESP
repository.name.fl_str_mv Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)
repository.mail.fl_str_mv biblioteca.csp@unifesp.br
_version_ 1814268399314796544